CANCER BIOMARKERS

The present invention relates to a method of prognosis for renal cell carcinoma in a subject, said method comprising determining the level and/or chemical composition of one or both of the glycosaminoglycans (GAGs) chondroitin sulfate (CS) and heparan sulfate (HS) in a body fluid sample, wherein sai...

Full description

Saved in:
Bibliographic Details
Main Authors GATTO FRANCESCO, NIELSEN JENS
Format Patent
LanguageChinese
English
Published 23.10.2018
Subjects
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to a method of prognosis for renal cell carcinoma in a subject, said method comprising determining the level and/or chemical composition of one or both of the glycosaminoglycans (GAGs) chondroitin sulfate (CS) and heparan sulfate (HS) in a body fluid sample, wherein said sample has been obtained from said subject. 本发明涉及种受试者中肾细胞癌的预测方法,所述方法包括测定体液样品中种或两种糖胺聚糖(GAG)硫酸软骨素(CS)和硫酸乙酰肝素(HS)的水平和/或化学组成,其中所述样品已从所述受试者获得。
Bibliography:Application Number: CN201780009605